Agenda

Friday February 07, 2025

• 12:00 PM – 1:00 PM

  Innovation Theater/Symposium (Non-Accredited)

• +

  1:00 PM – 3:00 PM

  Leukemia Landscape: Research and Clinical Advances (Part 1)

  • 1:00 PM – 1:20 PM
    Updates in the Diagnosis and Classification of Myeloid Malignancies
  • 1:20 PM – 1:40 PM
    Updates in Low/Intermediate Risk Myelodysplastic Syndromes
  • 1:40 PM – 2:00 PM
    Updates in High-Risk Myelodysplastic Syndromes
  • 2:00 PM – 2:20 PM
    Updates in Chronic Myeloid Leukemia
  • 2:20 PM – 2:40 PM
    From Data to Impact: Improving Clinical Decisions (Patient Case Presentation & Discussion)
  • 2:40 PM – 3:00 PM
    Questions & Answers
• 3:00 PM – 3:30 PM

  Expo Hall

• +

  3:30 PM – 5:30 PM

  Leukemia Landscape: Research and Clinical Advances (Part 2)

  • 3:30 PM – 3:50 PM
    Updates in Myeloproliferative Neoplasms
  • 3:50 PM – 4:10 PM
    Updates in Acute Lymphoblastic Leukemia
  • 4:10 PM – 4:30 PM
    Updates in Front Line Acute Myeloid Leukemia
  • 4:30 PM – 4:50 PM
    Updates in Relapsed Acute Myeloid Leukemia
  • 4:50 PM – 5:10 PM
    From Data to Impact: Improving Clinical Decisions (Patient Case Presentation & Discussion)
  • 5:10 PM – 5:30 PM
    Questions & Answers
• 5:30 PM – 6:30 PM

  Innovation Theater/Symposium (Non-Accredited)

• 6:30 PM – 7:30 PM

  Exhibit Hall Opening Reception

Saturday February 08, 2025

• 7:30 AM – 8:30 AM

  Innovation Theater/Symposium (Non-Accredited)

• +

  8:30 AM – 10:30 AM

  CLL Landscape: Research and Clinical Advances

  • 8:30 AM – 8:50 AM
    Updates in New Classifications and Risk Stratifications
  • 8:50 AM – 9:10 AM
    Updates in Bispecific Antibodies, Degraders, CAR-T Cells
  • 9:10 AM – 9:30 AM
    Updates in BTKi + BCL2 Therapy in the Retreatment Population
  • 9:30 AM – 9:50 AM
    Updates in the Management of BTK Resistance & Mutations
  • 9:50 AM – 10:10 AM
    From Data to Impact: Improving Clinical Decisions (Patient Case Presentation & Discussion)
  • 10:10 AM – 10:30 AM
    Questions & Answers
• 10:30 AM – 11:00 AM

  Expo Hall

• +

  11:00 AM – 1:00 PM

  Multiple Myeloma Landscape: Research and Clinical Advances (Part 1)

  • 11:00 AM – 11:20 AM
    Updates in basic science, pathophysiology, and diagnosis (including MRD & P53)
  • 11:20 AM – 11:40 AM
    Updates in Precursor Disorders
  • 11:40 AM – 12:00 PM
    Updates in Front Line – Transplant Eligible Multiple Myeloma
  • 12:00 PM – 12:20 PM
    Updates in Front Line – Transplant Ineligible Multiple Myeloma
  • 12:20 PM – 12:40 PM
    From Data to Impact: Improving Clinical Decisions (Patient Case Presentation & Discussion)
  • 12:40 PM – 1:00 PM
    Questions & Answers
• 1:00 PM – 2:00 PM

  Innovation Theater/Symposium (Non-Accredited)

• 2:00 PM – 2:30 PM

  Expo Hall

• +

  2:30 PM – 4:30 PM

  Multiple Myeloma Landscape: Research and Clinical Advances (Part 2)

  • 2:30 PM – 2:50 PM
    Updates in Relapsed Disease
  • 2:50 PM – 3:10 PM
    Updates in Relapsed or Refractory CAR-T Therapy
  • 3:10 PM – 3:30 PM
    Updates in Relapsed or Refractory Bispecific Antibody Treatment
  • 3:30 PM – 3:50 PM
    Updates in Relapsed or Refractory Novel Agents
  • 3:50 PM – 4:10 PM
    From Data to Impact: Improving Clinical Decisions (Patient Case Presentation & Discussion)
  • 4:10 PM – 4:30 PM
    Questions & Answers
• 4:30 PM – 5:30 PM

  Innovation Theater/Symposium (Non-Accredited)

• 5:30 PM – 6:30 PM

  Evening Reception

Sunday February 09, 2025

• 7:30 AM – 8:30 AM

  Innovation Theater/Symposium (Non-Accredited)

• +

  8:30 AM – 10:30 AM

  Lymphoma Landscape: Research and Clinical Advances (Part 1)

  • 8:30 AM – 8:50 AM
    Updates in Basic Science, Pathophysiology, and Diagnosis (including MRD, P53 & cDNA)
  • 8:50 AM – 9:10 AM
    Updates in Frontline Treatment of Diffuse Large B-Cell Lymphoma
  • 9:10 AM – 9:30 AM
    Updates in Relapsed Diffuse Large B-Cell Lymphoma
  • 9:30 AM – 9:50 AM
    Updates in Mantle Cell Lymphoma and Marginal Zone Lymphoma
  • 9:50 AM – 10:10 AM
    From Data to Impact: Improving Clinical Decisions (Patient Case Presentation & Discussion)
  • 10:10 AM – 10:30 AM
    Questions & Answers
• 10:30 AM – 11:30 AM

  Innovation Theater/Symposium (Non-Accredited)

• +

  11:30 AM – 1:30 PM

  Lymphoma Landscape: Research and Clinical Advances (Part 2)

  • 11:30 AM – 11:50 AM
    Updates in Frontline Treatment of Follicular Lymphoma
  • 11:50 AM – 12:10 PM
    Updates in Treatment of Relapsed Follicular Lymphoma
  • 12:10 PM – 12:30 PM
    Updates in Hodgkin Lymphoma
  • 12:30 PM – 12:50 PM
    Updates in T-Cell Lymphoma
  • 12:50 PM – 1:10 PM
    From Data to Impact: Improving Clinical Decisions (Patient Case Presentation & Discussion)
  • 1:10 PM – 1:30 PM
    Questions & Answers